Company: BDRX
Filing Date: 2025-11-24
Form Type: 424B3
Source: 0001214659-25-017136
Chunk: 21

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-24
Form: 424B3
Chunk 21
---
9.99%, which does not permit the selling      
 shareholder to exercise that portion of the warrants that would result in the selling shareholder 
 and its affiliates owning, after exercise, a number of our Ordinary Shares in excess of the       
 beneficial ownership limitation. The amounts and percentages in the table do not give effect      
 to the 9.99% beneficial ownership limitation, if applicable. The principal business address       
 of L1 Capital Global Opportunities Master Fund is 1688 Meridian Avenue, Level 6, Miami Beach,     
 FL 33139.                                                                                         |

| (14) | The selling shareholder holds Series                                                              
 D Warrants which entitle the selling shareholder to purchase an aggregate of 9,600,000 Ordinary   
 Shares (in the form of Depositary Shares), which we are registering hereby. The warrants          
 are subject to a beneficial ownership limitation of 9.99%, which does not permit the selling      
 shareholder to exercise that portion of the warrants that would result in the selling shareholder 
 and its affiliates owning, after exercise, a number of our Ordinary Shares in excess of the       
 beneficial ownership limitation. The amounts and percentages in the table do not give effect      
 to the 9.99% beneficial ownership limitation, if applicable. The principal business address       
 of Mercer Street Global Opportunity Fund, LLC is 1111 Brickell Avenue, Suite 2920, Miami,         
 FL 33131.                                                                                         |

| (15) | The selling shareholder holds Series                                                              
 D Warrants which entitle the selling shareholder to purchase an aggregate of 9,600,000 Ordinary   
 Shares (in the form of Depositary Shares), which we are registering hereby. The warrants          
 are subject to a beneficial ownership limitation of 9.99%, which does not permit the selling      
 shareholder to exercise that portion of the warrants that would result in the selling shareholder 
 and its affiliates owning, after exercise, a number of our Ordinary Shares in excess of the       
 beneficial ownership limitation. The amounts and percentages in the table do not give effect      
 to the 9.99% beneficial ownership limitation, if applicable. The principal business address       
 of S.H.N Financial Investments Ltd. is Arik Einstein 3, Herzliya, Israel.                         |

| (16) | The selling shareholder                                                                           
 holds Series D                                                                                    
 Warrants which entitle the selling shareholder to purchase an aggregate of 9,100,000 Ordinary     
 Shares (in the form of Depositary Shares), which we are registering hereby. The warrants          
 are subject to